Onkos Surgical Acquires the Juvenile Tumour System (JTS) from Stryker

June 13, 2022

Onkos Surgical entered into a definitive agreement to acquire the Juvenile Tumour System (JTS) extendible prosthesis from Stryker. The device enables non‑invasive implant lengthening for pediatric bone cancer and limb reconstruction cases, and the acquisition expands Onkos's musculoskeletal oncology product portfolio and clinical capabilities.

Buyers
Onkos Surgical
Targets
Juvenile Tumour System (JTS) extendible prosthesis
Sellers
Stryker
Industry
Medical Devices
Location
Michigan, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.